Edwards Lifesciences Corp cotiza a 85.74 USD y tiene una capitalización bursátil de $49.4B. En los últimos 12 meses ha facturado $6.5B con un margen de flujo de caja libre del 22.0%. Cotiza a 34.4 veces su flujo de caja libre (P/FCF) y a un PER de 49.1. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of va…
| Métrica | EW | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 78.0% | 57.0% | +21.0% |
| Operating Margin | 20.8% | -38.6% | +59.5% |
| Net Margin | 17.7% | -33.6% | +51.3% |
| FCF Margin | 22.0% | -13.9% | +35.9% |
| ROE | 10.4% | -40.4% | +50.8% |
| ROA | 7.8% | -32.0% | +39.8% |
| Current Ratio | 3.72 | 2.84 | +0.88 |
| Debt / Equity | 0.06 | 0.28 | -0.22 |